JXG vs TSLA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JXG presents as a classic value trap; while the Piotroski F-Score of 5/9 indicates stable short-term financial health and the balance sheet is lean (Debt/Equity 0.12), these are overshadowed by catastrophic growth trends. Earnings have collapsed by 81.7% YoY and the stock has lost over 99% of its value over five years. Despite an extremely low Price-to-Book ratio of 0.06, the lack of revenue growth and severe price depreciation suggest the market is pricing in significant asset impairment or business model failure.
Tesla's deterministic health is stable with a Piotroski F-Score of 4/9, but its valuation is fundamentally disconnected from current performance. The Graham Number ($22.85) and Intrinsic Value ($7.42) indicate extreme overvaluation relative to the current price of $343.25. With negative YoY revenue growth (-3.10%) and a collapse in earnings growth (-60.60%), the P/E ratio of 323.82 is unsustainable. Technical trends and insider activity are both strongly bearish, suggesting a significant correction is likely.
Compare Another Pair
Related Comparisons
JXG vs TSLA: Head-to-Head Comparison
This page compares JX Luxventure Group Inc. (JXG) and Tesla, Inc. (TSLA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.